Affiliation:
1. Krasnoyarsk branch of the «National Research Center for Hematology» Department of Health; Federal Research Center Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences
2. Krasnoyarsk regional clinic Hospital; Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
3. Krasnoyarsk regional clinic Hospital
4. «National Research Center for Hematology» Department of Health
5. Novosibirsk State Medical University
6. State-financed health care institution Irkutsk regional clinical hospital
Abstract
Simultaneous quantitative measurement of mRNA of the WT1, BAALC, EVI1, PRAME and HMGA2 genes in whole blood samples reflects the specific pathological proliferative activity in acute leukemia and their ratio is promising as a diagnostic marker. The transcriptome profile of acute leukemia cells is usually assessed using NGS or microarray techniques after a preliminary procedure for isolation of mononuclear cells. However, the results of using the multiplex PCR reaction for the simultaneous determination of all above mRNAs in whole blood samples have not been published so far. Determination of mRNA of WT1, BAALC, EVI1, PRAME and HMGA2 genes in venous blood level samples by multiplex RT-PCR. The study included 127 blood samples from patients who diagnosis of acute leukemia was subsequently confirmed. In the comparison group, 87 samples of patients without oncohematological diagnosis were selected, including 31 samples (K1) with a normal blood formula and 56 samples (K2) with a violation of the cellular composition - anemia, leukocytosis and thrombocytopenia. RNA isolation and reverse transcription were performed using the Ribozol-D and Reverta-L kits (TsNIIE, Russia). Determination of the mRNA expression level of the WT1, BAALC, EVI1, PRAME and HMGA2 genes by multiplex real-time PCR using a homemade multiplex PCR kit. The mRNA level was characterized by high interindividual variation and did not correlate with the rate of circulating leukocytes or blood blasts. Expression of WT1 mRNA was observed in whole blood only in one patient from the control group and in 112 (88%) patients with leukemia and was combined with a decrease in the level of HMGA2 mRNA expression and BAALC mRNA values. In contrast to the control groups, patients with leukemia had higher levels of BAALC mRNA in AML and ALL, increased PRAME mRNA in AML and APL, but lower levels of HMGA2 in APL.
Subject
Biochemistry (medical),Medical Laboratory Technology,General Medicine
Reference23 articles.
1. Zukhovitskaya E.V., Fiyas A.T. Molecular mechanisms of leukemia and problems in the treatment of acute leukemia: monograph. Grodno: Grodnenskiy gosudarstvennyi meditsinskiy universitet; 2015. (in Russian)
2. Handschuh L. Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies. J. Oncol. 2019; 2019: 7239206. https://doi.org/10.1155/2019/7239206
3. Savchenko V.G., Parovichnikova E.N., Afanasyev B.V., Troitskaya V.V., Gavrilina O.A., Sokolov A.N. et. al. Clinical guidelines for the diagnosis and treatment of acute lymphoblastic leukemias in adults. [Internet]. Available from: https://npngo.ru/uploads/media_document/293/556718e9-0ff5-46f3-bff8-bd592c83b992.pdf (accessed 30.03.2022). (in Russian)
4. Savchenko V.G., Parovichnikova E.N., Afanasyev B.V., Gritsaev S.V., Semochkin S.V., Bondarenko S.N. et al. Clinical recommendations for the diagnosis and treatment of acute myeloid leukemia in adults. 2018. [Internet]. Available from: https://npngo.ru/uploads/media_document/280/1889f8fa-440a-47fe-9040-a853983d85bd.pdf (accessed 30.03.2022). (in Russian)
5. Cilloni D., Renneville A., Hermitte F., Hills R.K., Daly S., Jovanovic J.V. et al. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. J. Clin. Oncol. 2009; 27(31): 5195-201. https://doi.org/10.1200/JCO.2009.22.4865